ClinicalTrials.Veeva

Menu

IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

I

Institut National de la Santé Et de la Recherche Médicale, France

Status

Enrolling

Conditions

Temple Syndrome
Silver Russell Syndrome
Prader-Willi Syndrome
Angelman Syndrome
Familial Precocious Puberty
Transient Neonatal Diabetes Mellitus
Beckwith-Wiedemann Syndrome
Pseudohypoparathyroidism
Kagami-Ogata Syndrome

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adults and children) affected with an ID regardless of the severity of the disease, with a molecular characterization, with a signed informed consent for all subjects, followed in one partner's center.

The main questions it aims to answer are:

  • Can we identify common metabolic profiles for all imprinted diseases?
  • Which imprinting disorders have an impact on the metabolic profiles of IDs?
  • Which are the metabolic risks associated to IDs?
  • Can we use the metabolic profiles for the clinical classification and prognosis of IDs?
  • Are there common therapeutic approaches for all IDs?

Enrollment

2,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients (adults and children) affected with an ID regardless of the severity of the disease
  • A confirmed diagnosis of ID (based on molecular diagnosis)
  • A signed informed consent for adults or signed informed consent of parents/guardians of minors/ protected adult.

Non-Inclusion Criteria:

There are no non-inclusion criteria.

Trial contacts and locations

18

Loading...

Central trial contact

Agnès LINGLART; Irène NETCHINE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems